From converting enzyme inhibition to angiotensin II receptor blockade: New insight on angiotensin II receptor subtypes in the kidney

被引:0
作者
Wolf, G [1 ]
Neilson, EG [1 ]
机构
[1] UNIV PENN, RENAL ELECTROLYTE & HYPERTENS DIV, PENN CTR MOL STUDIES KIDNEY DIS, PHILADELPHIA, PA 19104 USA
来源
EXPERIMENTAL NEPHROLOGY | 1996年 / 4卷
关键词
renin-angiotensin-system; kidney; AT(1) receptor; AT(2) receptor; ACE inhibitor;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Since the discovery of renin, almost 100 years ago, all the components of the renin-angiotensin system have been characterized on a molecular level. Angiotensin II (Ang II) receptors can be grouped in two classes: AT(1) and AT(2) receptors. In addition to these receptor subtypes, several other Ang-II-binding sites with different properties have been identified. The majority of Ang II receptors in the kidney comprises the AT(1) type, whereas AT(2) receptors are only expressed by distinct structures such as the renal capsule and the juxtaglomerular apparatus. The vast majority of physiological functions of angiotensin II in the kidney are mediated through AT(1) receptors. Important exceptions may be the pressure-induced natriuresis and chemotaxis for macrophages/ monocytes, as well as growth-suppressive effects which may be mediated by AT(2) receptors.
引用
收藏
页码:8 / 19
页数:12
相关论文
共 50 条
  • [1] Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus
    Johren, O
    Imboden, H
    Hauser, W
    Maye, I
    Sanvitto, GL
    Saavedra, JM
    BRAIN RESEARCH, 1997, 757 (02) : 218 - 227
  • [2] In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity
    Barra, JG
    Levenson, J
    Armentano, RL
    Fischer, EIC
    Pichel, RH
    Simon, A
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H859 - H868
  • [3] ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE KIDNEY
    EDWARDS, RM
    AIYAR, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (10): : 1643 - 1652
  • [4] Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
    Wong, J.
    Molyneaux, L.
    Constantino, M.
    Twigg, S. M.
    Yue, D. K.
    DIABETES OBESITY & METABOLISM, 2010, 12 (12) : 1072 - 1078
  • [5] Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis
    Godsel, LM
    Leon, JS
    Engman, DM
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (09) : 723 - 735
  • [6] Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension
    Doulton, TWR
    He, FJ
    MacGregor, GA
    HYPERTENSION, 2005, 45 (05) : 880 - 886
  • [7] Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
    Azizi, M
    Ménard, J
    CIRCULATION, 2004, 109 (21) : 2492 - 2499
  • [8] The angiotensin II type 2 receptor and the kidney
    Siragy, Helmy M.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2010, 11 (01) : 33 - 36
  • [9] Angiotensin converting enzyme and angiotensin II type I receptor polymorphisms in patients with coronary aneurysms
    Nicolas Lamblin
    Xavier Hermant
    Jean-Marc Lablanche
    Nicole Helbecque
    Philippe Amouyel
    Christophe Bauters
    Thrombosis Journal, 1 (1)
  • [10] Angiotensin-converting enzyme II in the heart and the kidney
    Danilczyk, U
    Penninger, JM
    CIRCULATION RESEARCH, 2006, 98 (04) : 463 - 471